School of Engineering, University of Glasgow, Glasgow, UK.
J R Soc Interface. 2010 Oct 6;7 Suppl 5(Suppl 5):S541-57. doi: 10.1098/rsif.2010.0229.focus. Epub 2010 Jun 30.
Biomaterials have been used to repair the human body for millennia, but it is only since the 1970s that man-made composites have been used. Hydroxyapatite (HA)-reinforced polyethylene (PE) is the first of the 'second-generation' biomaterials that have been developed to be bioactive rather than bioinert. The mechanical properties have been characterized using quasi-static, fatigue, creep and fracture toughness testing, and these studies have allowed optimization of the production method. The in vitro and in vivo biological properties have been investigated with a range of filler content and have shown that the presence of sufficient bioactive filler leads to a bioactive composite. Finally, the material has been applied clinically, initially in the orbital floor and later in the middle ear. From this initial combination of HA in PE other bioactive ceramic polymer composites have been developed.
生物材料已经被用于修复人体长达数千年,但直到 20 世纪 70 年代才开始使用人造复合材料。羟基磷灰石(HA)增强聚乙烯(PE)是第一代“第二代”生物材料之一,它被开发为具有生物活性而不是生物惰性。通过准静态、疲劳、蠕变和断裂韧性测试对其力学性能进行了表征,这些研究允许对生产方法进行优化。通过一系列填充剂含量的体外和体内生物学特性研究表明,存在足够的生物活性填充剂会导致生物活性复合材料的产生。最后,该材料已在临床上应用,最初用于眼眶底部,后来用于中耳。从最初的 HA/PE 组合开始,已经开发出了其他具有生物活性的陶瓷聚合物复合材料。